In last trading session, Altimmune Inc (NASDAQ:ALT) saw 5.24 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level of $7.71 trading at $0.52 or 7.23% at ring of the bell on the day assigns it a market valuation of $625.33M. That closing price of ALT’s stock is at a discount of -44.75% from its 52-week high price of $11.16 and is indicating a premium of 53.96% from its 52-week low price of $3.55.
For Altimmune Inc (ALT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.22. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Altimmune Inc (NASDAQ:ALT) trade information
Upright in the green during last session for gaining 7.23%, in the last five days ALT remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $7.71 price level, adding 0.26% to its value on the day. Altimmune Inc’s shares saw a change of 20.28% in year-to-date performance and have moved 11.90% in past 5-day. Altimmune Inc (NASDAQ:ALT) showed a performance of 35.03% in past 30-days.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 69.16% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -55.64% in reaching the projected high whereas dropping to the targeted low would mean a loss of -55.64% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.48% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 5.69% while estimates for its earnings growth in next 5 years are of 0.61%.
Altimmune Inc (NASDAQ:ALT)’s Major holders
BLACKROCK INC. is the top institutional holder at ALT for having 5.32 million shares of worth $35.39 million. And as of 2024-06-30, it was holding 7.5025 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.91 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9181 of outstanding shares, having a total worth of $32.63 million.
